CDDF multi-Stakeholder workshop on Impact of the Microbiome on Cancer Growth and Therapy
Munich, Germany – 15/16 February 2019
The CDDF multi-stakeholder workshop on Impact of the Microbiome on Cancer Growth and Therapy is organized by the Cancer Drug Development Forum (CDDF) in cooperation with the Munich Tumour Centre (TZM), with the aim of enhancing the understanding of the human microbiome and its critical role in cancer growth and treatment. The workshop provides comprehensive insights into the human microbiome and its application to cancer research as well as valuable opportunities to establish network in the emerging microbiome field.
The first edition of this workshop will be held on 15/16 February 2019 in Munich, Germany and will offer small group lectures and interactive discussions to effectively exchange expertise and broaden perspectives. The lectures will focus on the links between the human microbiome and cancer with a special attention to inflammation and immune system.
During the workshop, participants will enhance their knowledge of the current and future development in the microbiome research and its clinical relevance. Most importantly, delegates will network with various players and experts in the emerging microbiome sector.
The target audience is a multi-disciplinary community of researchers, medical oncologists, nutritionists and other healthcare professionals, representatives from pharmaceutical, nutrition and biomedical industries, patient advocates, and students who have a keen interest in microbiome research.
- Matthew Albert (Roche/Genentech, USA)
- Phillip Dennis (AstraZeneca, USA)
- Andreas Diefenbach (Charite – Universitaetsmedizin Berlin, Germany)
- Volkmar Nuessler (CDDF/Tumor Center, Munich, Germany)
- Giorgio Trinchieri (Center for Cancer Research/NCI/NIH, USA)
- Laurence Zitvogel (Gustave Roussy, France)
- Heinz Zwierzina (CDDF/Innsbruck University Hospital, Austria)
- View the meeting programme: PDF format
PRESENTATIONS: available soon
MEETING REPORT : available soon